Selected Publications

Rachel V Hatch, Craig W Freyer, Alison Carulli, Gretchen Redline, Daria V Babushok, Noelle V Frey, Saar I Gill, Elizabeth O Hexner, Selina M Luger, Mary Ellen Martin, Shannon R McCurdy, Alexander E Perl, David L Porter, Keith W Pratz, Edward A Stadtmauer, Alison W Loren : Day 4 vs. day 12 G-CSF administration following reduced intensity peripheral blood allogeneic stem cell transplant. J Oncol Pharm Pract 28(4): 892-897, Jun 2022.

Melody Smith, Anqi Dai, Guido Ghilardi, Kimberly V Amelsberg, Sean M Devlin, Raymone Pajarillo, John B Slingerland, Silvia Beghi, Pamela S Herrera, Paul Giardina, Annelie Clurman, Emmanuel Dwomoh, Gabriel Armijo, Antonio L C Gomes, Eric R Littmann, Jonas Schluter, Emily Fontana, Ying Taur, Jae H Park, Maria Lia Palomba, Elizabeth Halton, Josel Ruiz, Tania Jain, Martina Pennisi, Aishat Olaide Afuye, Miguel-Angel Perales, Craig W Freyer, Alfred Garfall, Shannon Gier, Sunita Nasta, Daniel Landsburg, James Gerson, Jakub Svoboda, Justin Cross, Elise A Chong, Sergio Giralt, Saar I Gill, Isabelle Riviere, David L Porter, Stephen J Schuster, Michel Sadelain Noelle Frey, Renier J Brentjens, Carl H June, Eric G Pamer, Jonathan U Peled, Andrea Facciabene, Marcel R M van den Brink, Marco Ruella : Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy. Nat Med 28(4): 713-723, Apr 2022.

Craig Freyer : Navigating the current CAR-T landscape for DLBCL: best practice panel perspectives. BMT Pharmacists Conference, American Society of Transplant and Cellular Therapy meeting, Salt Lake City, Utah. Apr 2022 Notes: "Oral Presentation"

Craig Freyer : Advancing Care for Patients Receiving CAR T-Cell Therapy: New Evidence and Opportunities for Oncology Pharmacy Practice. Hematology/Oncology Pharmacists Association (HOPA) annual meeting in Boston, MA. Apr 2022 Notes: "Oral Presentation"

Craig W Freyer, Alison W Loren. : Fluconazole-Induced adrenal insufficiency following allogeneic hematopoietic cell transplant. J Oncol Pharm Pract 10781552221087902, Mar 15 2022 Notes: doi: 10.1177/10781552221087902. Online ahead of print.

Molly E Graveno, Alison Carulli, Craig W Freyer, Brendan L Mangan, Robert Nietupski, Alison W Loren, Noelle V Frey, David L Porter, Saar I Gill, Elizabeth O Hexner, Selina M Luger, Mary Ellen Martin, Shannon R McCurdy, Alexander E Perl, Daria V Babushok, Keith W Pratz : Venetoclax in combination with hypomethylating agents or low dose cytarabine for relapsed and refractory acute myeloid leukemia. Leuk Lymphoma 8: 1-6, Mar 2022 Notes: doi: 10.1080/10428194.2022.2042688. Online ahead of print.

Craig W Freyer, Alison Carulli, Shannon Gier, Alex Ganetsky, Colleen Timlin Mindy Schuster, Daria Babushok, Noelle V Frey, Saar I Gill, Elizabeth O Hexner, Selina M Luger, James K Mangan, Mary Ellen Martin, Shannon R McCurdy, Alexander E Perl, David L Porter, Keith Pratz, Jacqueline Smith, Edward A Stadtmauer, Alison W Loren : Letermovir vs. high-dose valacyclovir for cytomegalovirus prophylaxis following haploidentical or mismatched unrelated donor allogeneic hematopoietic cell transplantation receiving post-transplant cyclophosphamide. Leuk Lymphoma Page: 1-9, Feb 2022 Notes: doi: 10.1080/10428194.2022.2042686. Online ahead of print.

Craig W Freyer, Michael Fradley, David Madnick, Joseph R Carver, Noelle V Frey, Saar I Gill, Bonnie Ky, Selina M Luger, Mary Ellen Martin, Shannon R McCurdy, Rupal O'Quinn, Alexander E Perl, Edward A Stadtmauer, Alison W Loren : Characterization of pericarditis following allogeneic stem cell transplantation. Transplant Cell Ther 27(11): 934.e1-934.e6, Nov 2021.

Craig W Freyer, Erin M Bange, Sarah Skuli, Miles Hsu, John Lin, Adam Cuker Adam D Cohen, Alfred Garfall : Carfilzomib-induced atypical hemolytic uremic syndrome in a patient with heterogeneous CFHR3/CFHR1 deletion treated with eculizumab. Clin Lymphoma Myeloma Leuk 21(11): e845-e849. Nov 2021.

Pankit Vachhani, Jeffrey Baron, Craig W Freyer, Austin Miller, Meir Wetzler, James E Thompson, Elizabeth A Griffiths, Eunice S Wang : A phase 2 trial of single low dose rasburicase for treatment of hyperuricemia in adult patients with acute leukemia. Leuk Res 107: 106588, Aug 2021 Notes: doi: 10.1016/j.leukres.2021.106588.